Radioiodinated and astatinated NHC rhodium complexes: Synthesis

Nuclear Medicine and Biology

Volumn 41, Issue S, 2014, Pages

  Rajerison, Holisoa ^a   Guérard, François ^a   Mougin Degraef, Marie ^a   Bourgeois, Mickael ^a,b   Da Silva, Isidro ^c   Chérel, Michel ^a   Barbet, Jacques ^a,b   Faivre Chauvet, Alain ^a   Gestin, Jean François ^a  

^a Groupe Cytokines et Récepteurs   (France)

^b GIP ARRONAX   (France)

^c CEMHTI UPR3079 CNRS Site Cyclotron   (France)

Author keywords

Astatine 211; Iodine 125; N heterocyclic carbene (NHC); Radioimmunotherapy; Rhodium

Indexed keywords

ASTATINE (1 BENZYL 3 NITROPHENYLIMIDAZOLIDENE)RHODIUM CHLORIDE COMPLEX AS 211; ASTATINE 211; IODINE (1 BENZYL 3 NITROPHENYLIMIDAZOLIDENE)RHODIUM CHLORIDE COMPLEX I 125; IODINE 125; RADIOISOTOPE; RHODIUM COMPLEX; UNCLASSIFIED DRUG; ASTATINE; HETEROCYCLIC COMPOUND; ORGANOMETALLIC COMPOUND; RADIOACTIVE IODINE; RHODIUM;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CHROMATOGRAPHY; CONCENTRATION (PARAMETERS); ENZYME STABILITY; HUMAN; IN VITRO STUDY; ISOTOPE LABELING; NUCLEOPHILICITY; RADIOCHEMISTRY; REACTION TIME; BLOOD; CHEMISTRY; DRUG STABILITY; PROCEDURES; SYNTHESIS;

ASTATINE; CHEMISTRY TECHNIQUES, SYNTHETIC; DRUG STABILITY; HETEROCYCLIC COMPOUNDS; HUMANS; IODINE RADIOISOTOPES; ISOTOPE LABELING; ORGANOMETALLIC COMPOUNDS; RHODIUM;

EID: 84899100628     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2013.12.004     Document Type: Article

References (46)

1. Zalutsky M.R., Reardon D.A., Pozzi O.R., Vaidyanathan G., Bigner D.D. Targeted alpha-particle radiotherapy with 211At-labeled monoclonal antibodies. Nucl Med Biol 2007, 34:779-785.
2. Guérard F., Gestin J.F., Brechbiel M.W. Production of [(211)At]-astatinated radiopharmaceuticals and applications in targeted a-particle therapy. Cancer Biother Radiopharm 2013, 28:1-20.
3. Chérel M., Davodeau F., Kraeber-Bodéré F., Chatal J.F. Current status and perspectives in alpha radioimmunotherapy. Q J Nucl Med Mol Imaging 2006, 50:322-329.
4. Sture Lindegren S., Bäck T., Jensen H.J. Dry-distillation of astatine-211 from irradiated bismuth targets: a time-saving procedure with high recovery yields. Appl Radiat Isot 2001, 55:157-160.
5. Yordanov A.T., Pozzi O., Carlin S., Akabani G., Wieland B., Zalutsky M.R. Wet harvesting of no-carrier-added 211At from an irradiated 209Bi target for radiopharmaceutical applications. J Radioanal Nucl Chem 2004, 262:593-599.
6. Visser G.W.M., Diemer E.L. Inorganic astatine chemistry: formation of complexes of astatine. Radiochim Acta 1983, 33:145-151.
7. Aaij C., Tschroots R.J.M., Lindner L., Feltkamp T.E.W. The preparation of astatine labelled proteins. Int J Appl Radiat Isot 1975, 26:25-30.
8. Vaughan A.T.M., Fremlin J.H. The preparation of astatine labelled proteins using an electrophilic reaction. Int J Nucl Med Biol 1978, 5:229-230.
9. Pillai K.K.R., McLaughlin W.W., Lambrecht R.R., Bloomer W.W. Carrier-free astatination of steroid hormones. J Label Compd Radiopharm 1987, 24:1117-1122.
10. Visser G.W.M., Diemer E.L., Kaspersen F.M. The preparation and stability of 211At-astato-imidazoles. Int J Appl Radiat Isot 1980, 31:275-278.
11. Vaidyanathan G., Affleck D.J., Bigner D.D., Zalutsky M.R. N-succinimidyl 3-[211At]astato-4-guanidinomethylbenzoate: an acylation agent for labeling internalizing antibodies with α-particle emitting 211At. Nucl Med Biol 2003, 30:351-359.
12. Talanov V.S., Garmestani K., Regino C.A.S., Milenic D.E., Plascjak P.S., Waldmann T.A., et al. Preparation and in vivo evaluation of novel stabilized linkers for 211At labeling of protein. Nucl Med Biol 2006, 33:469-480.
13. Harrison A., Royle L. Preparation of a 211At-IgG conjugate which is stable in vivo. Int J Appl Radiat Isot 1984, 35:1005-1008.
14. Zalutsky M.R., Narula A.S. Appl Radiat Isot 1988, 39:227-232.
15. Hadley S.W., Wilbur D.S., Gray M.A., Atcher R.W. Astatine-211 labeling of an antimelanoma antibody and its fragment using N-succimimidyl p-(211At)astatobenzoate: comparisons in vivo with the p-(125I)iodobenzoyl conjugate. Bioconjug Chem 1991, 2:171-179.
16. Vasaros L., Norseev Y., Nhan D.D., Khalkin V.A., Huan N.Q. Determination of the dissociation energy of the C-At bond in substituted astatobenzenes. J Radioanal Nucl Chem Lett 1984, 87:31-39.
17. Wilbur D.S., Chyan M.K., Hamlin D.K., Vessella R.L., Wedge T.J., Hawthorne M.F. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination. Bioconjug Chem 2007, 18:1226-1240.
18. Guerard F., Rajerison H., Faivre-Chauvet A., Barbet J., Meyer G., Da Silva I., et al. Radiolabelling of proteins with stabilised hypervalent astatine-211: feasibility and stability. J Nucl Med 2011, 52:1486.
19. Champion J., Alliot C., Renault E., Mokili B.M., Chérel M., Galland N., et al. Astatine standard redox potentials and speciation in acidic medium. J Phys Chem A 2010, 114:576-582.
20. Visser G.W.M., Diemer E.L., Kaspersen F.M. The preparation and stability of astatotyrosine and astato-iodotyrosine. Int J Appl Radiat Isot 1979, 30:749-752.
21. Meyer G.J., Roessler K., Stoecklin G. Reaction of aromatic diazonium salts with carrier-free radioiodine and astatine. Evidence of complex formation. J Am Chem Soc 1979, 101:3121-3123.
22. Pruszinski M., Bilewicz A., Was B., Petelenz B. Formation and stability of asta tide-mercury complexes. J Radioanal Nucl Chem 2006, 268:91-94.
23. Pruszyski M., Bilewicz A., Zalutsky M.R. Preparation of Rh[16aneS4-diol]211At and Ir[16aneS4-diol]211At Complexes as Potential Precursors for Astatine Radiopharmaceuticals. Part I: Synthesis. Bioconjugate Chem 2008, 19:958-965.
24. Wanzlick H.W. Aspects of nucleophilic carbene chemistry. Angew Chem 1962, 1:7-80.
25. Hahn F.E., Jahnke M.C. Heterocyclic carbenes; synthesis and coordination chemistry. Angew Chem Int Ed 2008, 47:3122-3172.
26. Arduengo A.J., Davidson F., Dias H.V.R., Goerlich J.R., Khasnis D., Marshall W.J., et al. An air stable carbene and mixed carbene "dimers". J Am Chem Soc 1997, 119:12742-12749.
27. Cavallo L., Correa A., Costabile C., Jacobsen H. Steric and electronic effects in the bonding of N-heterocyclic ligands to transition metals. J Organomet Chem 2005, 690:5407-5413.
28. Diez-Gonzälez S., Nolan S.P. Stereoelectronic parameters associated with N-heterocyclic carbene (NHC) ligands: a quest for understanding. Coord Chem Rev 2007, 251:874-883.
29. Leuthäuer S., Schwarz D., Plenio H. Tuning the electronic properties of N-heterocyclic carbenes. Chem Eur J 2007, 13:7195-7203.
30. Peris E. Routes to N-heterocyclic carbenes complexes. Top Organomet Chem 2007, 21:83-116.
31. Worm-Leonhard K., Meldal M. Green catalysts: solid-phase peptide carbene ligands in aqueous transition-metal catalysis. Eur J Org Chem 2008, 31:5244-5253.
32. Lemke J., Metzler-Nolte N. The synthesis of ruthenium and rhodium complexes with functionalized N-heterocyclic carbenes and their use in solid phase peptide synthesis. Eur J Inorg Chem 2008, 21:3359-3366.
33. Hindi K.M., Siciliano T.J., Durmus S., Panzner M.J., Medvetz D.A., Reddy D., et al. Synthesis, stability, and antimicrobial studies of electronically tuned silver acetate N-heterocyclic carbenes. J Med Chem 2008, 51:1577-1583.
34. Teyssot M.L., Jarrousse A.S., Manin M., Chevry A., Roche S., Norre F., et al. Metal-NHC complexes: a survey of anti-cancer properties. Dalton Trans 2009, 35:6894-6902.
35. Alliot C., Chérel M., Barbet J., Sauvage T., Montavon G. Extraction of astatine-211 in diisopropylether (DIPE). Radiochim Acta 2009, 97:161-165.
36. Sashuk V., Peeck L.H., Plenio H. [(NHC)(NHCewg)RuCl2(CHPh)] complexes with modified NHCewg ligands for efficient ring-closing metathesis leading to tetrasubstituted olefins. Chem Eur J 2010, 16:3983-3993.
37. Leuthäusser S., Schmidts V., Thiele C.M., Plenio H. π-Face Donor Properties of N-Heterocyclic Carbenes in Grubbs II Complexes. Chem Eur J 2008, 14:5465-5481.
38. Ogle J.W., Miller S.A. Electronically tunable N-heterocyclic carbene ligands: 1,3-diaryl vs. 4,5-diaryl substitution. Chem Comm 2009, 38:5728-5730.
39. Zinner S.C., Hermann W.A., Kühn F.E. Synthesis and characterization of asymmetric NHC complexes. J Organomet Chem 2008, 693:1543-1546.
40. Lucas C.C., King E.J. The iodometric titration of cysteine and allied substances. Biochem J 1932, 26:2076-2089.
41. Simonsen D.G. The oxidation of cysteine with iodine: formation of a sulfinic acid. J Biol Chem 1933, 101:35-42.
42. Visser G.M. Inorganic astatine chemistry: Part II. The chameleon behavior and electrophilicity of At-species. Radiochim Acta 1989, 47:97-103.
43. Pozzi O.R., Zalutsky M.R. Radiopharmaceutical chemistry of targeted radiotherapeutics, part 3: α-particle-induced radiolytic effects on the chemical behavior of 211At. J Nucl Med 2007, 48:1190-1196.
44. Misra A.K., Agnihotri G. Nitric acid mediated oxidative transformation of thiols to disulfides. Synth Commun 2004, 34:1079-1085.
45. Bourgeois M., Guerard F., Alliot C., Mougin-Degraef M., Rajerison H., Remaud-Le Saëc P., et al. Feasibility of the radioastatination of a monoclonal antibody with astatine-211 purified by wet extraction. J Labelled Compd Radiopharm 2008, 15:379-383.
46. Adam M.J., Wilbur D.S. Radiohalogens for imaging and therapy. Chem Soc Rev 2005, 34:153-163.